Case reports of complications from ketamine use in two MSM on ritonavir-based combinations
1 June 2012. Related: Conference reports, PK and drug interactions.
Conference reports
Intranasal and topical corticosteroids and risk of Cushing’s symptoms in HIV patients on ritonavir-based combinations
1 June 2012. Related: Conference reports, PK and drug interactions, Side effects.
Outcomes from switches to atazanavir/r in London
1 June 2012. Related: Conference reports, Antiretrovirals, Side effects.
Intimate partner violence towards HIV positive women in the UK
1 June 2012. Related: Conference reports, Women's health.
13th International workshop on Clinical Pharmacology of HIV Therapy, 16-18 April 2012, Barcelona
1 June 2012. Related: Conference reports, PK and drug interactions.
Studies on pipeline ARVs
1 June 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Washout pharmacokinetics of transplacental raltegravir in neonates
1 June 2012. Related: Conference reports, PK and drug interactions.
Interactions between malaria drugs and etravirine or darunavir/r
1 June 2012. Related: Conference reports, PK and drug interactions.
No interaction between antimalarial amodiaquine and nevirapine
1 June 2012. Related: Conference reports, PK and drug interactions.
Pharmacokinetics of atazanavir/ritonavir plus raltegravir
1 June 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Atazanavir/ritonavir and voriconazole not to be coadministered
1 June 2012. Related: Conference reports, PK and drug interactions.
Milk thistle (silymarin) and darunavir/ritonavir
1 June 2012. Related: Conference reports, PK and drug interactions.
Echinacea and etravirine
1 June 2012. Related: Conference reports, PK and drug interactions.
Warfarin and ARVs: impact of African American race and ritonavir
1 June 2012. Related: Conference reports, PK and drug interactions.
19th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 March 2012, Seattle
1 June 2012. Related: Conference reports.
HIV and the brain: longitudinal results from CHARTER and other studies
1 June 2012. Related: Conference reports, Coinfections and complications.
Systolic blood pressure and risk of myocardial infarction in HIV infection
1 June 2012. Related: Conference reports, Coinfections and complications.
Risk of non-AIDS defining malignancies and immune suppression
1 June 2012. Related: Conference reports, Coinfections and complications.
Renal impairment in the D:A:D study
1 June 2012. Related: Conference reports, Antiretrovirals, Coinfections and complications.
Early data for rilpivirine long acting formulation supports further investigation for PrEP
1 June 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Hormonal contraception: HIV transmission and progression rates
1 June 2012. Related: Conference reports, Women's health.
Darunavir use during pregnancy
1 June 2012. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.
19th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 March 2012
1 April 2012. Related: Conference reports.
Cure research takes centre stage: proof of concept for activating the latent reservoir
1 April 2012. Related: Conference reports, Cure-related research, Basic science and immunology.
Quad fixed-dose integrase combination: phase 3 studies at week 48
1 April 2012. Related: Conference reports, Antiretrovirals.
Dolutegravir studies continue to show promise
1 April 2012. Related: Conference reports, Antiretrovirals, Pregnancy.
Tenofovir prodrug: 10 day monotherapy study sets dose at 25 mg for easier coformulation
1 April 2012. Related: Conference reports, Antiretrovirals.
Paediatric formulations of ARVs: including an exciting new class
1 April 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Lower malaria risk in children receiving lopinavir/ritonavir-based compared to NNRTI-based ART
1 April 2012. Related: Conference reports, Paediatric care.
High prevalence of d4T-associated lipodystrophy including lipoatrophy in children
1 April 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Lopinavir/ritonavir monotherapy in children
1 April 2012. Related: Conference reports, Paediatric care.
Stopping treatment after early ART in infants
1 April 2012. Related: Conference reports, Paediatric care.
PrEP: PK modeling of daily TDF/FTC (Truvada) provides close to 100% protection against HIV infection
1 April 2012. Related: Conference reports, HIV prevention and transmission.
Risk of HIV reinfection may be similar to risk of initial HIV infection
1 April 2012. Related: Conference reports, HIV prevention and transmission.
Case report: homozygous CCR5 delta-32 protection overcome by infection with X4 virus
1 April 2012. Related: Conference reports, HIV prevention and transmission.
No association between atazanavir and MI or stroke in D:A:D study
1 April 2012. Related: Conference reports, Side effects, Coinfections and complications.
Hepatitis C coinfection studies
1 April 2012. Related: Conference reports, Hepatitis coinfection.
Herpes Zoster vaccine safe and effective in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides.
High dose flu vaccine improves antibody responses in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides.
2nd International Workshop on HIV & Women, 9-10 January 2012, Bethesda, USA
1 February 2012. Related: Conference reports.
Similar efficacy and a few gender related differences in side effects with rilpivirine vs efavirenz at 96-weeks
1 February 2012. Related: Conference reports, Antiretrovirals, Pregnancy.
The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women
1 February 2012. Related: Conference reports, Antiretrovirals, Women's health.
Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort
1 February 2012. Related: Conference reports, Women's health.
Poorer adherence and loss to follow up in Kenyan women who are pregnant when enrolled to ART programmes
1 February 2012. Related: Conference reports, Antiretrovirals, Pregnancy.
5th HIV Persistence Workshop on HIV Reservoirs, 6-9 December 2011, West Indies
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
Workshop report and commentary: HIV persistence and reservoirs
1 February 2012. Related: Conference reports, Cure-related research, Basic science and immunology, Virology.
13th European AIDS Conference (EACS), Belgrade, Serbia, 12-15 October 2011
1 December 2011. Related: Conference reports.
European guidelines (EACS) – 2011 update
1 December 2011. Related: Conference reports, Guidelines.
Raltegravir achieves superiority over efavirenz after four years
1 December 2011. Related: Conference reports, Antiretrovirals.
Higher plasma levels of tenofovir and darunavir but not efavirenz in older patients
1 December 2011. Related: Conference reports, PK and drug interactions.
Ritonavir levels reduced with high fat meal
1 December 2011. Related: Conference reports, PK and drug interactions, Nutrition.
Transplacental transfer of raltegravir and delayed plasma clearance in preterm neonates
1 December 2011. Related: Conference reports, Pregnancy.
2nd International Workshop on HIV and Ageing, Baltimore, Maryland, 27-28 October 2011
1 December 2011. Related: Conference reports.
Statin blocks negative impact of PIs on bone formation in vitro
1 December 2011. Related: Conference reports, Antiretrovirals.
HIV linked to frailty in middle-aged IDUs, especially with poor HIV control
1 December 2011. Related: Conference reports, Coinfections and complications.
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago, 17-20 September 2011
1 December 2011. Related: Conference reports.
Monitoring kidney function change with cobicistat
1 December 2011. Related: Conference reports, PK and drug interactions.
Intracellular raltegravir concentrations better with twice-daily than once-daily dosing
1 December 2011. Related: Conference reports, Antiretrovirals.
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 17-20 July 2011, Rome
1 October 2011. Related: Conference reports.
Cure research and viral reservoirs
1 October 2011. Related: Conference reports, Cure-related research, Basic science and immunology.
Orange Farm circumcision results dispel concerns about risk compensation
1 October 2011. Related: Conference reports, HIV prevention and transmission.
Randomised trial of ART in TB patients with high CD4 counts
1 October 2011. Related: Conference reports, TB coinfection.
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention 17-20 July 2011, Rome
1 August 2011. Related: Conference reports.
Webcasts for major research at IAS
1 August 2011. Related: Conference reports.
Treatment is prevention: ARV treatment in HPTN-052 reduces transmission by at least 96%: single transmission in treatment arm occurred before viral suppression
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.